The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kasikhina E.I.

State Educational Institution of additional professional education "Russian Academy of Continuous Medical Education"

Intermittent terbinafine regimens in the treatment of mycoses of dermatophyte etiology

Authors:

Kasikhina E.I.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2013;11(5): 11‑16

Read: 16873 times

Download PDF (RU)
Contact the author
Table of contents

INTERMITTENT TERBINAFINE REGIMENS IN THE TREATMENT OF MYCOSES OF DERMATOPHYTE ETIOLOGY
INTERMITTENT TERBINAFINE REGIMENS IN THE TREATMENT OF MYCOSES OF DERMATOPHYTE ETIOLOGY

To cite this article:

Kasikhina EI. Intermittent terbinafine regimens in the treatment of mycoses of dermatophyte etiology. Russian Journal of Clinical Dermatology and Venereology. 2013;11(5):11‑16. (In Russ.)

 
Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The review contains the data of foreign and Russian clinical trials of the efficiency and safety of different pulse terbinafine therapy regimens in the treatment of superficial mycoses of dermatophyte etiology.

Keywords:

terbinafine
pulse therapy
mycoses
dermatophyte onichomycosis

Authors:

Kasikhina E.I.

State Educational Institution of additional professional education "Russian Academy of Continuous Medical Education"

Close metadata

References:

  1. Hiruma M., Matsushita A., Kobayashi M., Ogawa H. One week pulse therapy with itraconazole (200 mg day) for onychomycosis. Evaluation of treatment results according to patient background. Mycoses 2001; 44: 87-93.
  2. Gupta A.K., Lynde C.W., Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001; 44: 485-491.
  3. Narain U., Bajaj A.K., Misra K. Onychomycosis. Ind J Dermatol 2002; 47: 68-75.
  4. Heikkila H., Stubb S. Long-term results of patients with onychomycosis treated with itraconasole. Acta Dermatol Venereol 1997; 38: 70-71.
  5. Hiruma M., Matsushita A., Kobayashi M., Ogawa H. One week pulse therapy with itraconasole - 200 mg/day) for onychomycosis. Evaluation of treatment results according to patient background. Mycoses 2001; 44: 87-93.
  6. Sigurgeirsson B., Olaffson J.H., Steinsson J. et al. Long-term effectiveness of treatment with terbinafine vs. itraconazole in onychomycosis. Arch Dermatol 2002; 138: 353-357.
  7. Jansen R., Redekop W.K., Rutten F.F. Cost effectiveness of continuous terbinafine compared with intermittent itraconasole in the treatment of dermatophyte toenail onychomycosis: analysis of based on results from the LION-study. Pharmacoeconomics 2001; 19: 401-410.
  8. Faergemann J., Zehender H., Denouel J., Milleroux L. Levels of terbinafine in plasma, stratum corneum, dermisepidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day four weeks. Acta Dermatol Venerol 1993; 73: 305-309.
  9. Hazen K.C. Evaluation of in vitro susceptibility of dermatophytes to oral antifungal agents. J Am Acad Dermatol 2000; 43: 5: Suppl: S125-S129.
  10. Shuster S., Munro S.C. Single dose treatment of fungal nail disease. Lancet 1992; 339: 1066.
  11. Tosti A., Piraccini B.M., Stinchi C., Venturo N. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996; 34: 595-600.
  12. Alpsoy E., Yilmaz E., Basaran E. Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach. J Dermatol 1996; 23: 259-262.
  13. Warshaw E.M., Carver S.M., Zielke G.R., Ahmed D.D.F. Intermittent terbinafine for toenail onychomycosis: is it effective? Result of a randomized pilot trial. Arch Dermatol 2001; 137: 9: 1253.
  14. Sanmano B., Hiruma M., Mizoguchi M., Ogawa H. Combination therapy consisting of 1-week pulse of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis. J Dermatol Treat 2004; 15: 1-7.
  15. Zaias N., Rebell G. The successful treatment of Trichophyton rubrum nail bet (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol 2004; 140: 691-695.
  16. Nakano N., Hiruma M., Shiraki Y., Chen X., Porgpermdee S., Ikeda S. Combination of pulse therapy with terbinafine tablets (500 mg day for 1 week + following 3 weeks interval) and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study. J Dermatol 2006; 33: 753-758.
  17. Gianni C. Update on antifungal therapy with terbinafine. G Ital Dermatol Venereol 2010; 145: 3: 415-424.
  18. Jaiswal A., Sharma R.P., Garg A.P. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Indian J Dermatol Venereol Leprol 2007; 73: 6: 393-396.
  19. Gupta A.K., Paquet M., Simpson F., Tavakkol A. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol 2012; 28: 5: 245-250.
  20. Sergeev A.Yu. Sistemnaya terapiya onikhomikozov. Consilium Medicum 2001; 3: 4: 44-49.
  21. Bogush I.G., Kripitser O.A., Stelias Kiriakos Minas. Pul's-terapiya peroral'nym terbinafinom v kombinatsii s terbinafinom kremom v terapii dermatofitiinykh onikhomikozov. Uspekhi med mikol 2007; 10: 130-130.
  22. Rukavishnikova V.M. Mikozy stop. Izd. 2-e, pererab. i dop. M: Eliks­Kom 2003; 332.
  23. Kasikhina E.I., Savchenko N.V. Dzheneriki terbinafina v Rossii: vzglyad prakticheskogo mikologa. Klin dermatol venerol 2012; 5: 80-84.
  24. Hu Y., Yang L.J., Wei L., Dai X.Y. et al. Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26: 12: 988-991.
  25. Claxton A.J., Cramer J., Pierce C. A systematic review of the association between dose regimens and medication compliance. Clin Ther 2001; 23: 8: 1296-1310.
  26. Gupta A.K., Lynch L.E., Kogan N., Cooper E.A. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol 2009; 23: 3: 256-262.
  27. Pavlotsky F., Armoni G., Shemer A., Trau H. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J Dermatol Treat 2004; 15: 5: 315-320.
  28. Mishra M., Panda P., Tripathy S., Sengupta S. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis. Indian J Dermatol Venereol Leprol 2005; 71: 4: 262-266.
  29. Sikder A.U., Mamun S.A., Chowdhury A.H., Khan R.M. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. Mymensingh Med J 2006; 15: 1: 71-80.
  30. Chang C.H., Young-Xu Y., Kurth T., Orav J.E. The safety of oral antifungal treatment for superficial dermatophytosis and onychomycosis: metaanalisis. Am J Med 2007; 120: 9: 791-798.
  31. Takahata Y., Hiruma M., Shiraki Y., TokuhisaY. et al. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for 1 week). Mycoses 2008; 52: 72-76.
  32. Shivakumar V., Rajendra Okade, Rajkumar V. et al. Intermittent pulse-doses terbinafine in the treatment of tinea corporis and / or tinea cruris. Indian J Dermatol 2011; 56: 1: 121-122.
  33. Ungpakorn R., Ayutyanont T., Reangchainam S. et al. Treatment of Micro­sporum spp. tinea capitis with pulsed oral terbinafine. Clin Exp Dermatol 2004; 29: 3: 300-303.
  34. Gupta A.K., Adamiak A., Cooper E.A. The efficacy and safety of terbinafine in children. J Eur Acad Dermatol Venereol 2003; 17: 627-640.
  35. Devliotou-Panagiotidou D., Koussidou-Eremondi T.H. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. J Eur Acad Dermatol Venereol 2004; 18: 155-159.
  36. Bennassar A., Grimalt R. Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol 2010; 3: 89-98.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.